Katarina Uttervall
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 24
- Chronic Myeloid Leukemia Treatments 3
-
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 2
- Co-authors
- Hareth Nahi (17 shared papers)Evren Alici (10 shared papers)Gösta Gahrton (8 shared papers)Johan Lund (5 shared papers)Johan Liwing (5 shared papers)J Aschan (5 shared papers)Erik Holmberg (2 shared papers)Adil Doganay Duru (2 shared papers)
- Journals
- Blood (6 papers)European Journal Of Haematology (6 papers)Journal of Clinical Oncology (3 papers)HemaSphere (2 papers)Cancer Medicine (2 papers)
- Partner nations
- SwedenUnited StatesFrance
In The Last Decade
Katarina Uttervall
25 papers receiving 242 citations
Peers
Comparison fields: 5 of 28
- Hematology 194
- Oncology 95
- Genetics 22
- Molecular Biology 83
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Katarina Uttervall
This map shows the geographic impact of Katarina Uttervall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Uttervall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Uttervall more than expected).
Fields of papers citing papers by Katarina Uttervall
This network shows the impact of papers produced by Katarina Uttervall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Uttervall. The network helps show where Katarina Uttervall may publish in the future.
Co-authors
The 25 scholars most cited alongside Katarina Uttervall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 43 | |
| 2 | 2017 | 39 | |
| 3 | 2019 | 23 | |
| 4 | 2023 | 20 | |
| 5 | 2022 | 19 | |
| 6 | 2011 | 19 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2024 | 9 | |
| 10 | 2019 | 7 | |
| 11 | 2024 | 7 | |
| 12 | 2015 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2013 | 4 | |
| 16 | 2013 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2012 | 2 | |
| 20 | 2021 | 2 |
About Katarina Uttervall
Katarina Uttervall is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 245 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers), Ubiquitin and proteasome pathways (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (194 citations), Oncology (95 citations), Genetics (22 citations), Molecular Biology (83 citations) and Radiology, Nuclear Medicine and Imaging (23 citations). Katarina Uttervall has collaborated with scholars based in Sweden, United States and France. Frequent co-authors include Hareth Nahi, Evren Alici, Gösta Gahrton, Johan Lund, Johan Liwing, J Aschan, Erik Holmberg, Adil Doganay Duru, Markus Hansson and Kristina Carlson. Their work appears in journals such as Blood, European Journal Of Haematology, Journal of Clinical Oncology, HemaSphere and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.